There’s always something going on in the world of medical devices, including in the policy, regulatory and legal spheres. Following is a trio of quick updates on stories that have emerged since the start of the year. FDA pre-emption back in play The question of FDA’s pre-emption of state regulation (via tort law) of medical devices has resurfaced. This involves Medtronic yet again, leading one to wonder if these pivotal pre-emption cases ever involve anyone else. Stengel v. Medtronic went the company’s way when a three-judge panel...